The Wall Street Journal: Valeant to change its name to Bausch Health

0
137
views

Valeant Pharmaceuticals International Inc. VRX, +0.78%  plans to change its name to Bausch Health Cos., as management takes another step toward remaking the company and distancing it from past controversies.

The name change, which the company is to announce Tuesday as it reports first-quarter earnings, will take effect in July and come with a new logo, branding and the ticker BHC on the New York and Toronto stock exchanges, Chief Executive Joseph Papa said in an interview.

“We think this name captures who we really are becoming,” Papa said. “We are much more than a pharmaceutical company.”

The company will still keep the names of its businesses, such as Salix for the unit that sells gastrointestinal drugs.

An expanded version of this report appears on WSJ.com.

Popular on WSJ.com:

The mystery of Michael Flynn’s guilty plea

NBC bet $69 million on Megyn Kelly — then viewers vanished